BRPI0917668A2 - antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain - Google Patents

antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain

Info

Publication number
BRPI0917668A2
BRPI0917668A2 BRPI0917668A BRPI0917668A BRPI0917668A2 BR PI0917668 A2 BRPI0917668 A2 BR PI0917668A2 BR PI0917668 A BRPI0917668 A BR PI0917668A BR PI0917668 A BRPI0917668 A BR PI0917668A BR PI0917668 A2 BRPI0917668 A2 BR PI0917668A2
Authority
BR
Brazil
Prior art keywords
antibody
producing
disease
treating
nucleic acid
Prior art date
Application number
BRPI0917668A
Other languages
Portuguese (pt)
Inventor
William Clarke Adam
James Pow Andrew
Gerard Doyle Anthony
Wai Bernadete
Dorothy Poulton Lynn
Antony Jennings Philip
Original Assignee
Cephalon Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904178A external-priority patent/AU2008904178A0/en
Application filed by Cephalon Australia Pty Ltd filed Critical Cephalon Australia Pty Ltd
Priority claimed from PCT/AU2009/001047 external-priority patent/WO2010017598A1/en
Publication of BRPI0917668A2 publication Critical patent/BRPI0917668A2/en

Links

BRPI0917668A 2008-08-14 2009-08-14 antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain BRPI0917668A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8902808P 2008-08-14 2008-08-14
AU2008904178A AU2008904178A0 (en) 2008-08-14 Anti-IL-12/23 Antibodies
PCT/AU2009/001047 WO2010017598A1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies

Publications (1)

Publication Number Publication Date
BRPI0917668A2 true BRPI0917668A2 (en) 2019-09-24

Family

ID=66215484

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917668A BRPI0917668A2 (en) 2008-08-14 2009-08-14 antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain

Country Status (2)

Country Link
BR (1) BRPI0917668A2 (en)
CL (1) CL2011000319A1 (en)

Also Published As

Publication number Publication date
CL2011000319A1 (en) 2012-02-03

Similar Documents

Publication Publication Date Title
BRPI0922106A2 (en) isolated monoclonal antibody, isolated nucleic acid molecule, host cell, method for producing an isolated monoclonal antibody, pharmaceutical composition, and use of the composition
BRPI0822099A2 (en) isolated binding member, use of an isolated binding member, method for treating a disorder, isolated nucleic acid molecule, host cell, and method for producing a binding member
BRPI0813645A2 (en) METHODS FOR MODIFYING ANTIBODIES, AND MODIFIED ANTIBODIES WITH PERFECT FUNCTIONAL PROPERTIES
BRPI0919879A2 (en) methods for purifying single domain antigen binding molecules
BRPI0817182A2 (en) Method for purifying an antibody and compositions
BRPI0917204A2 (en) structural antibody variants for better therapeutic characteristics
IL287311A (en) Antibodies and processes for their preparation
BRPI0922122A2 (en) compositions and methods for treating celiac disease.
PT2853545T (en) SPECIFIC ANTIBODY FOR IGE
BRPI0905761A2 (en) Humanized antibody or binding fragment thereof, isolated nucleic acid, vector, host cell, method for producing a humanized antibody or binding fragment thereof, composition, method for treating a vwf-mediated disease or disorder in an individual, use of a humanized antibody or binding fragment thereof, method for administering the humanized antibody or binding fragment thereof, article of manufacture and kit
BRPI0918842A2 (en) method for treating multiple sclerosis patients with anti-il2r antibodies
IL198379A (en) Humanized antibodies and antibody fragments that specifically bind sphingosine-1-phosphate, nucleic acids encoding the same and compositions and methods for use thereof to treat disease
BRPI0716872A2 (en) Phospholipases, nucleic acids encoding them and methods for their manufacture and use
BRPI0812446A2 (en) METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES
BRPI1008692A2 (en) antibody molecules having human ox40 specificity.
BRPI0906786A2 (en) Compound, process for preparing a compound, use of a compound, method for treating a disease or condition, pharmaceutical composition, process for preparing a pharmaceutical composition, product, and kit.
BRPI0818244A2 (en) Compound, pharmaceutical composition, use of a compound, and method for treating a disorder or disease
CR10705A (en) ANTIBODIES FOR LYMPHOTOXINE-ALFA
BRPI0918178A2 (en) monoclonal antibodies for cancer treatment
BRPI0919377A2 (en) isolated antibody or antigen-binding fragment of the same, isolated nucleic acid, vector, host cell, pharmaceutical composition, method of producing said antibody or fragment, use thereof, and composition comprising said antibody or fragment
BRPI0814688A2 (en) compound, use of a compound, methods for producing an antiproliferative effect on a warm-blooded animal, and for treating disease, and, pharmaceutical composition
BR112014000341A2 (en) antigen binding protein, method for treating a patient with a disease, use of an antigen binding protein, nucleic acid, and host cell
BRPI0819211A2 (en) Anti-hepcidin antibodies and uses thereof, polynucleotide, recombinant expression vector, process for producing an antibody, pharmaceutical composition, immunoassay and kit for carrying it out
BRPI0811635A2 (en) ARILAZOL-2-IL CYANOETHYLAMINE COMPOUNDS, METHODS FOR MAKING THEM AND METHODS FOR THE USE OF THEM
PT2427212T (en) ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.